Related Experiment Video
Updated: Dec 28, 2025

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
RelB suppresses type I Interferon signaling in dendritic cells
Irene Saha1, Hemant Jaiswal1, Richa Mishra2
1Laboratory of Innate Immunity, National Institute of Immunology, New Delhi, India.
Insights
Relb acts as a novel negative regulator of type I interferon signaling in dendritic cells. This finding reveals a new mechanism for controlling immune responses and dendritic cell development.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Type I Interferon (IFN) signaling is crucial for dendritic cell (DC) development and function.
- Hyperactive type I IFN signaling can impede the development of the cDC2 subtype.
- Relb is a known transcription factor essential for cDC2 development.
Purpose of the Study:
- To investigate the role of Relb in modulating type I IFN signaling within dendritic cells.
- To understand the molecular mechanisms by which Relb influences IFN responses.
- To determine the impact of Relb on cDC2 development in the context of IFN signaling.
Main Methods:
- Analysis of type I IFN signaling in Relb-expressing and Relb-deficient dendritic cells (FL-DCs, cDC2 cultures).
- Assessment of Interferon-Stimulated Genes (ISGs) and IκBα levels.
- Utilizing Ifnar1 knockout mice to study cDC2 development in the absence of IFN signaling.
Main Results:
- Relb suppresses homeostatic type I IFN signaling in cDC2 cultures.
- TLR stimulation induced RelB, which correlated with decreased IFN signatures and ISG levels.
- Relb's inhibitory effect on IFN signaling is mediated by increased IκBα levels.
- Relb deficiency led to dampened antiviral responses due to elevated ISG levels.
- cDC2 developmental defects in Relb null mice were rescued in an Ifnar1-deficient background.
Conclusions:
- Relb functions as a novel negative regulator of the type I IFN signaling pathway.
- Relb fine-tunes type I IFN signaling, impacting dendritic cell development, particularly the cDC2 subtype.
- This study elucidates a new mechanism controlling immune homeostasis and DC subtype differentiation.
Abstract:
Type I Interferon (IFN) signaling plays a critical role in dendritic cell (DC) development and functions. Inhibition of hyper type I IFN signaling promotes cDC2 subtype development. Relb is essential to development of cDC2 subtype and here we analyzed its effect on type I IFN signaling in DCs. We show that Relb suppresses the homeostatic type I IFN signaling in cDC2 cultures. TLR stimulation of FL-DCs led to RelB induction coinciding with fall in IFN signatures; conforming with the observation Relb expression reduced TLR stimulated IFN induction along with decrease in ISGs. Towards understanding mechanism, we show that effects of RelB are mediated by increased levels of IκBα. We demonstrate that RelB dampened antiviral responses by lowering ISG levels and the defect in cDC2 development in RelB null mice can be rescued in Ifnar1-/- background. Overall, we propose a novel role of RelB as a negative regulator of the type I IFN signaling pathway; fine tuning development of cDC2 subtype.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Regulation of the Unfolded Protein Response
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Experimental RNAi
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

